KoBioLabs (Korea) Today
| 348150 Stock | KRW 4,705 30.00 0.64% |
PerformanceVery Weak
| Odds Of DistressLow
|
KoBioLabs is trading at 4705.00 as of the 18th of March 2025, a 0.64 percent increase since the beginning of the trading day. The stock's open price was 4675.0. KoBioLabs has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. KoBioLabs is traded on Korean Securities Dealers Automated Quotations in South Korea. More on KoBioLabs
Moving against KoBioLabs Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
KoBioLabs Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. KoBioLabs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding KoBioLabs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Founder CEO | GwangPyo Ko |
KoBioLabs (348150) is traded on KOSDAQ in Korea and employs 41 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 192.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KoBioLabs's market, we take the total number of its shares issued and multiply it by KoBioLabs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
KoBioLabs has accumulated about 52.69 B in cash with (12.48 B) of positive cash flow from operations.
Check KoBioLabs Probability Of Bankruptcy
Ownership AllocationThe market capitalization of KoBioLabs is W192.58 Billion. KoBioLabs shows large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check KoBioLabs Ownership Details
KoBioLabs Risk Profiles
Although KoBioLabs' alpha and beta are two of the key measurements used to evaluate KoBioLabs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.57 | |||
| Standard Deviation | 1.9 | |||
| Variance | 3.61 | |||
| Risk Adjusted Performance | (0.11) |
KoBioLabs Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in KoBioLabs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Other Information on Investing in KoBioLabs Stock
KoBioLabs financial ratios help investors to determine whether KoBioLabs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KoBioLabs with respect to the benefits of owning KoBioLabs security.